Bereskin & Parr reconnu dans l’édition 2020 de IAM Patent 1000

Nous sommes heureux d’annoncer que Bereskin & Parr figure à nouveau cette année dans l’édition 2019 de IAM Patent 1000 au Canada:

• Cabinet de poursuite de brevets – Classement or
• Cabinet de contentieux de brevets – Classement argent
• Transactions de brevets – Cabinet recommandé

Félicitations aux professionnels suivants inclus dans le classement 2020:

Extrait du classement [en anglais]:

“The service, quality of work and responsiveness at Bereskin & Parr are consistently at an excellent level. From initial mining sessions to identify patentable inventions and filing applications through to enforcement and commercialisation, you can confidently trust the squad to do the heavy lifting and make the process as painless as possible – all while keeping your best interests in mind.” Managing partner Micheline Gravelle heads the life sciences group and co-heads the patents and cannabis practice groups. With a rich background working at multinationals, government agencies and a hospital laboratory, she is a wise choice for non-contentious instructions. The gold-standard prosecution team also includes chemical group lead and former research scientist Patricia Folkins; mechanical and industrial processes guru Philip Mendes da Costa; and Robert Storey, the industrial designs chair, who has chalked up four decades of patenting experience. The firm also has a robust litigation strike force in the form of Andrew McIntosh, Robert MacFarlane, Adam Bobker, Donald Cameron and Scott MacKendrick. “Exceptional at planning and coordinating disputes, Andrew gets results and effectively deals with opposing counsel.” He teamed up with MacFarlane and Bobker to defend NOVA Chemicals in a 19-day damages trial; the trio persuaded the court to adopt, for the first time ever, a full absorption accounting method in an accounting of profits case which led to a significant reduction in the amount payable by their client. Meanwhile, Cameron and MacKendrick have been duking it out for two GlaxoSmithKline companies. Electrical and computer technology division captain Bhupinder Randhawa loves helping businesses to extract maximum value from their assets, especially in exciting new areas such as AI. High-rolling licensing mandates are all in a day’s work for Victor Krichker – who recently helped the LCG Group to acquire a majority stake in Toronto Research Chemicals – and Noel Courage, a life sciences and regulatory whizz who also lectures widely on his subject ofchoice.”

Pour plus d’informations sur IAM Patent 1000, visitez www.iam-media.com.